Researchers Discover Receptor's Role In Glaucoma And Other Eye Diseases
April 3, 2008
Adapted from Texas A&M Health Science Center Institute of Biosciences and Technology at Houston
Researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology at Houston have uncovered a receptor's role in the development of certain eye diseases, including glaucoma, and its regulation could help in development of corresponding treatments.
The study is currently available online in the Proceedings of the National Academy of Sciences and will be in an upcoming issue of the journal.
In their study, Liu Mingyao Liu, Ph.D., found that a receptor, called Gpr4,8 plays an important role in the development of the front portion of the eye. Abnormal development may result in glaucoma, a leading cause of blindness that affects an estimated 70 million people worldwide.
Further research may lead to new therapeutic drugs for glaucoma that target this receptor.
View all news updates for glaucoma
Disclaimer: The information provided in this section is a public service of the BrightFocus Foundation, and should not in any way substitute for the advice of a qualified healthcare professional, and is not intended to constitute medical advice. Although we take efforts to keep the medical information on our website updated, we cannot guarantee that the information on our website reflects the most up-to-date research. Please consult your physician for personalized medical advice; all medications and supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical product or therapy.
Some of the content in this section is adapted from other sources, which are clearly identified within each individual item of information.